RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia. Pham LT, Peng H, Ueno M, Kohno S, et al. Biochem Biophys Res Commun 2022;621:74-79.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pham LT, Peng H, Ueno M, Kohno S, et al. RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia. Biochem Biophys Res Commun 2022;621:74-79.
PMID: 35810594